Microba Life Sciences Ltd

Microba Investor Hub - Webinars

Microba Investor Hub

Microba Investor Hub - Corporate Governance

Microba Investor Hub - Shareholder Information

Corporate

Microba Investor Hub - News & Media

Microba Investor Hub - Announcements

DM Sans

Microba Life Sciences CEO Luke Reid speaks with Proactive at the ASX Small and Mid-Cap Conference September 2022. Microba is advancing healthcare through precision microbiome science. The company believes comprehensive and precise measurement of the human gut microbiome is required to drive innovation in medical care. Its therapeutic discovery is generating multiple potent therapeutic candidates to address unmet clinical needs for multiple chronic diseases.

Proactive ASX Small and Mid-Cap Conference (ASX: MAP)